Fertility control with norethindrone enanthate, a long-acting parenteral progestogen
Kesserü-Koós, E.; Larrañaga-Legufa, A.; Hurtado-Koo, H.; Scharff, H.J.
Acta Europaea Fertilitatis 4(4): 203-221
1973
ISSN/ISBN: 0587-2421 PMID: 4802108 Document Number: 62922
Document emailed within 1 workday
Related Documents
Kesserü-Koós, E.; Larrañaga-Legufa, A.; Hurtado-Koo, H.; Scharff, H.J. 1973: Fertility control with norethindrone enanthate, a long-acting parenteral progestogen Acta Europaea Fertilitatis 4(4): 203-221Zañartu, J.; Navarro, C. 1968: Fertility inhibition by an injectable progestogen acting for 3 months. a clinical survey of 130 fertile women treated with norethisterone enanthate Obstetrics and Gynecology 31(5): 627-633
Rice-wray, E.; Schulz-contreras, M.; Guerrero, I.; Aranda-rosell, A. 1962: Long-term administration of norethindrone in fertility control JAMA 180(5): 355-358
Tyler, E.T.; Olson, H.J.; Gotlib, M.; Levin, M.; Behne, D. 1964: Long Term Usage of Norethindrone with Mestranol Preparations in the Control of Human Fertility Clinical Medicine 71: 997-1024
Wintrob, R.M. 1970: Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment Diseases of the Nervous System 31(Suppl): 50-62
Zanartu, J.; Onetto, E. 1973: Long acting injectable progestogens in human fertility control INT PLANNED PARENTHOOD FED CLINICAL PROCEEDINGS OF FIRST INTERNATIONAL PLANNED PARENTHOOD FEDERATION SOUTH-EAST ASIA and OCEANIA REGIONAL MEDICAL and SCIENTIFIC CONGRESS SYDNEY, AUSTRALIA, AUG 14-18, 1972 250P ILLUS AUSTRALIAN and NEW ZEALAND JOURNAL OF OBSTETRICS and GYNAECOLOGY: MELBOURNE, AUSTRALIA 65-79
Zañartu, J.; Rice-Wray, E.; Goldzieher, J.W. 1966: Fertility control with long-acting injectable steroids. A preliminary report Obstetrics and Gynecology 28(4): 513-515
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Power, J.; Guillebaud, J. 2002: Long-acting progestogen contraceptives Practitioner 246(1634): 332; 335-341
Plesner, R. 1969: Contraception by an injectable, long-acting oestrogen-progestogen agent Acta Endocrinologica 61(3): 494-508
Li, X.F.; Davies, G.C.; Newton, J. 1992: A review of the effects of long-acting progestogen-only contraceptives on ovarian activity Advances in Contraception: the Official Journal of the Society for the Advancement of Contraception 8(1): 1-19
Neme, B.; von Atzingen, I.J.; Salomão, A.J.; Santos, E.P.; Behle, I. 1971: 0.35 mg of norethindrone in the control of human fertility Maternidade E Infancia; Arquivos Medicos-Sociais 30(3): 297-315
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Who 1982: Multinational comparative clinical trial of long acting injectable contraceptives norethisterone enanthate given in 2 dosage regimens and depot medroxy progesterone acetate Contraception 25(1): 1-12
Who 1982: Multinational comparative clinical trial of long acting injectable contraceptives norethisterone enanthate given in 2 dosage regimens and depot medroxy progesterone acetate Contraception 25(1): 1-12
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Asnake, M.; Henry, E.G.; Tilahun, Y.; Oliveras, E. 2013: Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 123 Suppl. 1: E29-E32